Results 201 to 210 of about 37,334 (230)
Some of the next articles are maybe not open access.
Cardiac resynchronization therapy
British Journal of Hospital Medicine, 2013This article provides an overview of cardiac resynchronization therapy. At the end of the article, the reader should be familiar with the indications, risks and complications of cardiac resynchronization therapy and important areas of debate.
V, Cobb, M, Thomas
openaire +3 more sources
Cardiac Resynchronization Therapy
JACC: Clinical Electrophysiology, 2022Abstract This chapter examines cardiac resynchronization therapy (CRT), or biventricular pacing (BVP), which is now well established as a therapeutic option for selected, symptomatic patients with heart failure due to left ventricular systolic dysfunction and reduced ejection fraction (HFrEF) and a prolonged QRS interval.
Varun Sundaram, Judith A. Mackall
openaire +2 more sources
Cardiac resynchronization therapy
Current Cardiology Reports, 2002Despite advances in medical therapy for patients with congestive heart failure, morbidity and mortality remain high. Conventional atrioventricular pacing with a short atrioventricular delay was first introduced as a nonpharmacologic treatment for patients with severe heart failure.
Silke Isabelle, Trautmann +2 more
openaire +4 more sources
Cardiac resynchronization therapy.
Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular, 2012Heart failure can potentially complicate all forms of heart disease. Over the last 20 years, there has been a significant increase in both its incidence and prevalence due to the advancing age of the population and improved survival from coronary heart disease – the principal cause of heart failure.
Maria C Valéria Braga Braile, Sternieri +1 more
+7 more sources
Cardiac Resynchronization Pacing Therapy
Cardiology, 2004Approximately one third of patients with congestive heart failure and systolic dysfunction have an intraventricular conduction delay that is manifested as a QRS duration >120 ms. An intraventricular conduction delay adversely affects ventricular performance by causing dyssynchrony in ventricular activation.
Cash, Casey, Bradley P, Knight
openaire +2 more sources
Cardiac Resynchronization Therapy
Progress in Cardiovascular Diseases, 2006Left ventricular (LV) dysynchrony, generally defined as the effect of intraventricular conduction defects or bundle branch block to produce nonsynchronous ventricular activation, places the failing heart at a further mechanical disadvantage. The deleterious effects of ventricular dysynchrony include suboptimal ventricular filling, paradoxical septal ...
openaire +3 more sources
Cardiac Resynchronization Therapy
La Revue du praticien, 2010Fifteen years after the birth of resynchronization therapy, this technique has become one of the recommended treatments in severe heart failure patients, with low ejection fraction (4 35%), and conduction disorders (ORS > or = 120 ms). Based on large randomized clinical trials, the European recommendation is class I type (level of evidence A), to ...
Jeffrey Wing-Hong Fung, Cheuk-Man Yu
openaire +3 more sources
Cardiac Resynchronization Therapy
Heart Failure Clinics, 2015José María Tolosana, Lluís Mont
+4 more sources
Cardiac Resynchronization Therapy
Cardiac Electrophysiology Clinics, 2019Thakur R., Natale A.
openaire +2 more sources